What are the latest advances in Gastroparesis?

The most promising advances in Gastroparesis research currently focus on gastric per-oral endoscopic myotomy (G-POEM), novel prokinetic agents, and the exploration of gastric electrical stimulation to improve symptom management.

Current Research Directions

Recent clinical focus has shifted toward minimally invasive procedures like G-POEM, which has shown significant potential in improving gastric emptying and reducing symptoms for patients with refractory Gastroparesis. Researchers are also investigating the role of the gastric microbiome and the enteric nervous system, specifically targeting interstitial cells of Cajal, the "pacemaker" cells of the stomach, to restore normal motility. While gene therapy remains in the early, pre-clinical conceptual stage, the medical community is increasingly optimistic about precision medicine approaches that categorize patients based on their specific underlying etiology—whether diabetic, idiopathic, or post-surgical.

Clinical Trials and Diagnostic Tools

New diagnostic tools are evolving beyond traditional scintigraphy, with wireless motility capsules (SmartPill) and electrogastrography providing more granular data on gastric transit. Several clinical trials currently recruiting on ClinicalTrials.gov are evaluating the efficacy of novel serotonin receptor agonists and ghrelin receptor agonists, which aim to stimulate gastric contractions more effectively than current therapies. To participate in these studies, we encourage patients to search ClinicalTrials.gov using the term "Gastroparesis" and filter by "Recruiting" status to find trials near their location.

Leading Institutions

Research consortia such as the NIDDK-funded Gastroparesis Clinical Research Consortium (GpCRC) are leading the effort to standardize diagnostic criteria and treatment protocols for Gastroparesis. While these research timelines are inherently unpredictable, the increased collaboration between global academic centers and patient advocacy groups like the International Foundation for Gastrointestinal Disorders (IFFGD) is accelerating the pace of discovery for those living with Gastroparesis.

Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Gastroparesis


• International Foundation for Gastrointestinal Disorders (IFFGD)


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


• PubMed: Recent clinical advancements in gastric motility disorders